Fibrinolysis
"Fibrinolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The natural enzymatic dissolution of FIBRIN.
| Descriptor ID |
D005342
|
| MeSH Number(s) |
G09.188.390.150.390
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolysis".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolysis".
This graph shows the total number of publications written about "Fibrinolysis" by people in this website by year, and whether "Fibrinolysis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 0 | 2 | | 2002 | 1 | 2 | 3 | | 2003 | 3 | 1 | 4 | | 2005 | 2 | 1 | 3 | | 2006 | 1 | 0 | 1 | | 2007 | 2 | 1 | 3 | | 2008 | 2 | 1 | 3 | | 2009 | 2 | 1 | 3 | | 2010 | 2 | 0 | 2 | | 2011 | 2 | 3 | 5 | | 2013 | 0 | 3 | 3 | | 2014 | 4 | 0 | 4 | | 2015 | 7 | 2 | 9 | | 2016 | 1 | 1 | 2 | | 2017 | 6 | 0 | 6 | | 2018 | 1 | 0 | 1 | | 2019 | 6 | 2 | 8 | | 2020 | 4 | 1 | 5 | | 2021 | 1 | 2 | 3 | | 2022 | 2 | 2 | 4 | | 2023 | 1 | 2 | 3 | | 2024 | 0 | 1 | 1 | | 2025 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrinolysis" by people in Profiles.
-
Ruzzene ST, Berry AR, Garcia VP, Valenti WB, Izaias JE, Stockelman KA, Greiner JJ, Park AJ, Stauffer BL, DeSouza CA. Obesity-related elevation in circulating endothelial-derived extracellular microvesicles and endothelial fibrinolytic dysfunction. Am J Physiol Heart Circ Physiol. 2026 Jan 01; 330(1):H319-H326.
-
Moore HB, Moore PK, Schwartz DA, Luyendyk JP. Fibrin and Fibrinolysis in Liver, Kidney, and Lung Transplantation. Arterioscler Thromb Vasc Biol. 2026 Jan; 46(1):37-50.
-
Thielen O, Erickson C, Stocker B, Schaid TR, Gallagher LT, Dickinson K, Ramser B, Sen S, Hansen K, Moore E. Thromboinflammatory mediators produced by hyperfibrinolysis following injury. J Trauma Acute Care Surg. 2026 Mar 01; 100(3):460-468.
-
Moore PK, Moore EE, Garner R, Hansen K, Barrett CD, Sauaia A, Chandler J, Janssen WJ, Moore HB. Coagulation factor XIII: An unrecognized regulator of fibrinolytic phenotypes in trauma-A potential link to cysteine cathepsin degradation of plasminogen. J Trauma Acute Care Surg. 2026 Feb 01; 100(2):271-280.
-
Stegman RD, Schmitt LR, Hansen KC, Kayden A, Ghosh A, Metjian A, Wohlauer MV. Proteomics of arterial thrombi in acute limb ischemia. J Thromb Thrombolysis. 2025 Oct; 58(7):866-881.
-
Maginot ER, Gawargi FI, Moore EE, White CM, Volk GE, Moody TB, Sextro KS, Hiser D, Tierney JF, Sheppard OO, Evans CH, Cantrell E, Kamien AJ, Lamb GD, Matos M, Veatch J, Cloonan MR, Chandler JG, Moore HB, Moore PK, Sauaia A, Bernhardt IM, Yaffe MB, Bauman ZM, Henry R, Barrett CD. Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax. J Trauma Acute Care Surg. 2026 Jan 01; 100(1):20-27.
-
Maginot ER, Moore HB, Moore EE, Barmettler NK, Moody TB, Volk GE, Sextro KS, Hiser DC, Clegg AA, Gawargi FI, White CM, Henry R, Chandler JG, Yaffe MB, Nydam TL, Barrett CD. Change in novel plasmin activated clotting time assay predicts hyperfibrinolysis, massive transfusion, and mortality in trauma in under 3 minutes. Am J Surg. 2025 Dec; 250:116476.
-
Smith CF, Baldé MA, French S, Modahl CM, Bahrabadi L, Amponsah-Asamoah M, Larson KY, Maroney SP, Galindo DC, Millimouno M, Camara N, Benjamin J, Brandehoff NP, McCabe MC, Cohen MJ, Jackson K, Baldé C, Castoe TA, Mackessy SP, Hansen KC, Saviola AJ. Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics. J Thromb Haemost. 2025 Jul; 23(7):2198-2212.
-
Barrett CD, Moore PK, Moore EE, Moore HB, Chandler JG, Siddiqui H, Maginot ER, Sauaia A, Pérez-Calatayud AA, Buesing K, Wang J, Davila-Chapa C, Hershberger D, Douglas I, Pieracci FM, Yaffe MB. Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis. Chest. 2025 Jan; 167(1):67-75.
-
Rodriguez IE, Saben JL, Moore EE, Knudson MM, Moore PK, Pieracci F, Sauaia A, Moore HB. Fibrinolysis Resistance After Injury Is a Risk Factor for a Hospital-Acquired Pneumonia-Like Disease Pattern. Surg Infect (Larchmt). 2024 Mar; 25(2):87-94.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|